Clinical research
The therapy demonstrated durable and statistically significant improvements in a number of efficacy endpoints measured 12 months after infusion.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 15, 2020.
Bristol Myers Squibb released new data from two clinical trials of Opdivo plus Yervoy-based combinations in non-small cell lung cancer and updated results from the KarMMa trial of ide-cel for multiple myeloma being developed with bluebird bio.
Genentech, a Roche company, announced positive results from the Phase II CITYSCAPE clinical trial in PD-L1-positive metastatic non-small cell lung cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 14, 2020.
The company announced positive data from the Phase III KEYNOTE-355 trial looking at Keytruda in combination with chemotherapy as first-line treatment for metastatic triple-negative breast cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 13, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 12, 2020.
They expect to share the complete findings with regulators in the upcoming months and make a final decision on whether to continue the clinical trial.
The company expects to submit a New Drug Application to the U.S. Food and Drug Administration in the second half of this year, with plans, if approved, to launch the drug in the fourth quarter of 2021.
PRESS RELEASES